Ideas For Now-

Here's a little gossip on the Co- An insider publication medRxiv? published a advance copy of a report, they call it a " Preprint " on a study that like so many in this industry was paid for by HOLX lets get that strait... and this pre print has not been certified by peer review but it is interesting))))

" regarding the performance characteristics of a high throughput automated transcription mediated amplification test for SARS-CoV-2 detection has been published by medRxiv. The "results provide validation evidence for a sensitive and specific method for pandemic-scale automated molecular diagnostic testing for SARSCoV2," according to the authors, who are all scientists employed by Hologic, the manufacturer of the diagnostic test systems used in this study, except 1 -> manuscript is being circulated by traders.

That was about a week ago... The important part of this is ->' pandemic scale ' testing. This is what is missing from us being able to get the upper hand on Covid.
 
Motley Fools---
Could Golden Nugget Online Gaming Become the Next DraftKings?
Golden Nugget is an early leader in the fast-growing online gambling market.

Last month, Golden Nugget Online Gaming announced it would be coming to the public markets through a merger with special-purpose acquisition company (SPAC) Landcadia Holdings II (NASDAQ:LCA). Shares of Landcadia spiked after the announcement as investors cheered the opportunity to gain exposure to the fast-growing online gambling market.

Going public via a SPAC
Golden Nugget Online Gaming isn't going public through a traditional IPO process. Instead, an already-public special-purpose acquisition company (SPAC) will be bringing it public through acquisition. SPAC IPOs are not new, but they have risen in prominence in recent years as an attractive way for private companies to go public faster.

In this case, Landcadia Holdings II, a SPAC managed by billionaire businessman Tilman Fertitta, is acquiring Golden Nugget Online Casino for $745 million. The deal still needs to be approved by Landcadia's shareholders and by regulators before it can close; however, Landcadia is already a public company, which means investors can buy the stock in anticipation of the deal closing to gain exposure.

The deal is expected to close in the third calendar quarter of 2020, and when it does, the trading symbol will change to "GNOG" from "LCA."


Growth in online gambling
Investors are excited over the Golden Nugget Online Gaming IPO because the company is a way to play the fast-growing online gambling industry.

There is a lot of hype around the potential size of the online gambling market in the U.S. as states have started to legalize sports gambling. Golden Nugget Online Gaming focuses on iGaming, or online casino gambling, which consists of online slot machines and online card games such as poker. Although not as many states have legalized online casino gambling, a few -- including New Jersey, Pennsylvania, and Michigan -- have./////

I am more interested in Sports wagering than these virtual casinos... & would favor Draftkings, Fanduel... Could Eldorado get involved?

Also the guy behind all of this is the fill in guy on Shark Tank he owns an NBA team and


Related-party transaction

Despite the enticing growth story, there is a sticking point with the deal that investors should be aware of. Tilman Fertitta, the manager of the Lancadia SPAC, is also the owner of the Golden Nugget Casino, which is selling the online casino to the SPAC. In other words, Fertitta is on both sides of the transaction as a seller and a buyer, which technically makes the acquisition a related-party transaction.

Fertitta's involvement as both a buyer and a seller should be carefully scrutinized by investors as it constitutes a conflict of interest in some regards. Golden Nugget Casino is wholly owned by Landry's, a holding company owned by Fertitta; however, Fertitta doesn't own a majority of Landcadia shares. Therefore, Fertitta is a net seller of the online casino and has some influence over the buyer... Whooooooo

 
stonedinvestor said:
Oh no that can't happen Van my wife has planted all these flowers above the tank. Tons of $'s in those flowers we can't disturb them.

Why can't he just go down the hole himself and walk the bag out to the corners? A little man. Please! Honestly I'm freaking out over all of this-- what happened to the dye .... it came out on the hill I'm worried about!!! I'm fine with the gravel and pipe but track-hoe sounds like back hoe..... Ayyyyyy.


Folks I want to lay out an investment here the last one we added to the Ideas For Now Portfolio was Hologic. Do you even remember? I absolutely owe you all a list of ideas in the account and the ideas I have been monitoring but not in yet... I need to somehow get these 48 pasges into one list... I myself am getting dizzy.

But this is the effort it takes if you want to invest from home.

Hologic I have known for a long time. Back in the breast cancer days... (my Mom had it years ago) this was the imaging stock to own and their sales of all sorts of machines are down because of the Hospitals toning down or turning off their non emergency surgeries, as they come back on the earnings at these med supply co's goes back up.. it's a trend we can use in analyzing a bunch of other companies too. But part of hat HOLX does is testing and it always has been.

And they have a machine they call The Panther! This is a very good machine. Good boy! Panther is very very fast. Now this test uses bleach. This has been a small problem as in transit to HOLX from various hospitals and medical centers a lot of folks use reagents that interact with bleach in a bad way. In fact the joke is a toxic gas cyanide like can form and that's not good news for ambulance drivers. But this Panther test is not only is fast, it can do many many tests at once...

So the Goal here is--> How do we get this Amazing Test With a 2 Hr turnaround to the masses without blowing everybody up...It can't be that hard.

Watch this vid of the CEO as he shows how he clamps the sample in the tube and the tube already had gunk in it and off it goes to HOLX... I think they have figured it out! And come next earnings period we are all going to find out That Hologic is a $77 stock.

Look behind the CEO at the screen the stk was $50 in April... $60 in July.... HOLX should announce upwards of 1 million tests per week.


More...

Looks good. But why this?

upload_2020-7-19_11-36-33.png

It would be nice to see some open market buys.
 
Feeling reflective today. I did some digging and it wasn't Jack Clark... it was someone worse- Kirk Gibson. This is the play that sent me to the poorhouse. Let me set the scene-- I am at Logan airport in Boston about to board a shuttle plane to NYC-- I am spending my winnings, on top of the world, I'm paying for other people... when this guy with two busted legs, a bad arm, a bloody eye and anal abrasions steps to the plate. Someone I had been assured was not playing in this game.
 
I hope I'm not starting to forget things. There have been two examples in this thread of me forgetting stuff-- my grotto problem and the Taser company usually I'm smart as a whip. But I've gone through a lot lately... just been a real slog and throw ontop of that a bean bag chair... Never ever order one of those folks... Especially from Europe... Anyway, I write down these symbols and most of them I know-- FLIR look up Fleer K-12 that education company, DKNG self explained and FIS? Why did I write this down? I've never heard of the company...

Now my long experience in this game tells me not to throw out the idea but research it there must be a reason you wrote down those letters .

June 23->FIS price target raised to $152 from $140 at JPMorgan 06/23 FIS JPMorgan analyst Tien-tsin Huang raised the firm's price target on FIS to $152 from $140 and keeps an Overweight rating on the shares. With expectations lowered following the Q1 results and business mix better understood, the analyst likes the stock's risk/reward from here. Huang prefers FIS in the mid-term for the "underappreciated positive revision potential in its non-merchant segment."

Alright... Now it gets confusing:Fiserv downgraded to Perform at Oppenheimer 06/29 FISV, FIS, GPN NOT FIS...! But read why--

As previously reported, Oppenheimer analyst Glenn Greene downgraded Fiserv (FISV) to Perform from Outperform. The analyst thinks investors play Fiserv versus FIS (FIS) and Fiserv has significantly outperformed FIS over this cycle. Greene sees FIS as now better positioned to capture evolving trends for large FIs to outsource tech capabilities, and views Global Payments (GPN) as the best positioned pure play payments company as it's not as beholden to cross border spend. Thus, investors can take advantage of a rebounding economy in payments without significant revenue mix headwinds, he contends.

Next up->FIS price target raised to $161 from $145 at Oppenheimer 06/29 FIS Oppenheimer analyst Glenn Greene raised the firm's price target on FIS to $161 from $145 as he now sees FIS as better positioned to capture evolving trends for large FIs to outsource tech capabilities. The analyst keeps an Outperform rating on the shares.

Not to be outdone! Here comes Sasquatch-FIS margins should show sequential progress throughout year, says Susquehanna 07/07 FIS Susquehanna analyst James Friedman raised his estimates for FIS as he believes margins should improves sequentially each quarter for the remainder of the year. The analyst does note that the soft sales cycle in Capital Markets from Q1 likely waterfalls into softer revenues for the remainder of 2020. Friedman maintained his Positive rating and $170 price target on FIS shares.
Wow big PT with a warning....

Goldman last Tus-->FIS initiated with a Buy at Goldman Sachs 05:03 FIS Goldman Sachs analyst Matthew O'Neill initiated coverage of FIS with a Buy rating and $164 price target. The analyst started 15 companies in the Payments & IT Services space, favoring companies with "strong secular growth trends" and those with the opportunity for total addressable market expansion. Further, COVID-19 will accelerate greater adoption of contactless payments and e-commerce, benefiting the networks, acquirers and processors, O'Neill tells investors in a research note. He believes FIS's recurring revenue stream will drives "consistent/durable growth" and mitigate the near-term impact from COVID-19.

Same day pushy guy Argus rushes into the room: FIS initiated with a Buy at Argus 07:29 FIS Argus analyst Stephen Biggar initiated coverage of FIS with a Buy rating and $160 price target.

And today-FIS price target raised to $164 from $150 at Stephens

WoooooHa. This stock back in Feb was ten dollars higher... Feb 13 = $154
FIS today is $140. Contactless payments this sounds like Paypal or something.
They report AUG 4th. Like square I have to wonder about small businesses merchants that are no longer there... But can so many analysts all be wrong?

WATCH)))
FIS-$140.00
 
This idea we tossed around last week-- luckily I found this:
->Ingevity Has the Right Mix for an Upside Breakout
Here's how to play this specialty chemicals stock.
:NGVT


During Thursday night's Lightning Round onMad Moneyone caller asked Jim Cramerabout Ingevity Corp. (NGVT) . "This is the kind of industrial I'd want to buy right here," said Cramer.

Let's check out the charts and indicators of this manufacturer of specialty chemicals.

In the daily bar chart of NGVT, below, we can see that the shares were in a decline from last July to late March. Prices have recovered from the March low and now things are looking up. NGVT is trading above the rising 50-day moving average line and the declining 200-day moving average line is only a few dollars above the market.

The trading volume was heavy from February to April suggesting a change in ownership from weak hands to strong hands. The On-Balance-Volume (OBV) line has been rising from March and tells us that buyers of NGVT have been more aggressive.

The Moving Average Convergence Divergence (MACD) oscillator is turning up from the zero line for a fresh buy signal.

17cbd130-c830-11ea-acfb-73dee5b70292.gif

In the weekly bar chart of NGVT, below, we can see that prices were in a bear phase from early 2019. NGVT has rebounded this year. Prices are still below the declining 40-week moving average line but this is a lagging indicator.
The weekly OBV line has been rising which tells us that buyers of NGVT are more aggressive for the first time in the past three years. The MACD oscillator gave a cover shorts buy signal in late April and is pointed up toward the zero line.
23aee0a1-c830-11ea-acfb-edd65fd92a33.gif

In this daily Point and Figure chart of NGVT, below, we can see a potential upside price target of $70.
 
You must log in or register to reply here.
Back
Top